Femasys Inc FEMY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.10
- Day Range
- $1.96–2.19
- 52-Week Range
- $1.96–22.20
- Bid/Ask
- $2.03 / $2.13
- Shares Outstanding
- 8.38M
- Market Cap
- $17.17M
- Volume/Avg
- 252,635 / 707,515
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.72
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 54
- Website
- https://www.femasys.com
Valuation
|
Metric
|
FEMY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 2.72 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
FEMY
|
|---|---|
Quick Ratio | 0.41 |
Current Ratio | 2.14 |
Interest Coverage | −8.13 |
Quick Ratio
FEMY
Profitability
|
Metric
|
FEMY
|
|---|---|
Return on Assets (Normalized) | −70.90% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −96.39% |
Return on Assets
FEMY
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|RpxK@rH? | LOCK|XN | $138B | |||
| Becton Dickinson & Co
BDX
| LOCK|rYT | LOCK|#?d< | $48B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|%k>Yx^ | LOCK|&Ntq | $31B | |||
| ResMed Inc
RMD
| LOCK|WQPwQdmd | LOCK|<psQ | $31B | |||
| Alcon Inc
ALC
| LOCK|kcyKkw# | LOCK|jn@H | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|^@BF^F$ | LOCK|VKR | $26B | |||
| Solventum Corp
SOLV
| LOCK|LM&?%Xd | LOCK|&> | $15B | |||
| Baxter International Inc
BAX
| LOCK|FV | LOCK|Dcxd | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|%%?gW@L | LOCK|xPsg | $11B | |||
| Repligen Corp
RGEN
| LOCK|^#K@C<WJ | LOCK|qk>%> | $10B |
United States